Plain-English translation of NCT05611242 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
When you have a certain type of acute stroke caused by a blockage in your carotid artery (the major blood vessel in your neck that supplies blood to your brain), doctors need to act quickly to restore blood flow. This trial is comparing two emergency treatment approaches: one that uses a mechanical clot-removal device without placing a stent in your carotid artery, and another that uses the same clot-removal device but also places a stent (a small metal tube) to prop open your carotid artery. The goal is to find out which approach works better for patients like you.
Carotid artery blockages during acute stroke are serious and require emergency treatment, but doctors are not sure whether adding a stent to the standard clot-removal procedure actually improves outcomes for patients. This trial exists to answer that question and help guide future treatment decisions.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to receive one of two emergency procedures. Both include the standard clot-removal treatment, but one group will also receive a stent in the carotid artery. The doctors will choose the order of the procedures based on what they think is best for you at that moment. After treatment, you will be checked at 3 months and 1 year after the procedure by doctors who were not involved in your care, using standard stroke recovery tests. Some of these follow-up visits may be done remotely if available at your hospital.
AI-generated summary from trial data ยท Jun 16, 2026 ยท Not medical advice
United States